4th Quarter - Report
VENN STRATEGIES for ELI LILLY AND COMPANY
Firm
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General Healthcare Issues pertaining to Eli Lilly and Company, including but not limited to drug pricing, importation, and innovation policies.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SAMUEL GOODSTEIN | — |
| MICHAEL SPIRA | — |
Copyright/Patent/Trademark CPT
Proposals on patent policy impacting biopharmaceutical innovation.
| Lobbyist | Covered position, as disclosed |
|---|---|
| SAMUEL GOODSTEIN | — |
| MICHAEL SPIRA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.